Probiotics Bifidobacterium lactis M8 and Lactobacillus rhamnosus M9 prevent high blood pressure via modulating the gut microbiota composition and host metabolic products

mSystems. 2023 Dec 21;8(6):e0033123. doi: 10.1128/msystems.00331-23. Epub 2023 Oct 19.

Abstract

Elevated blood pressure affects 40% of the adult population, which accounts for high cardiovascular disease risk and further high mortality yearly. The global understanding of the gut microbiome for hypertension may provide important insights into the prevention. Bifidobacterium lactis M8 and Lactobacillus rhamnosus M9 originated from human breast milk, were able to decrease blood pressure, and modified metabolites in a high fructose-induced elevated blood pressure mouse model. Moreover, we found there was a close relationship between unexplored gut microbes and elevated blood pressure. Also, subsequently, the cross-link was explored among gut microbes, metabolites, and some metabolic pathways in gut microbial environment through introducing novel prediction methodology and bioinformatic analysis. It allowed us to hypothesize that probiotics can prevent elevated blood pressure via gut microbiota and related metabolism.Thus, utilization of dietary strategies (such as probiotics) to maintain the blood pressure level is of crucial importance.

Keywords: efficacy; hypertension; metabolome; metagenome; probiotics.

MeSH terms

  • Adult
  • Animals
  • Bifidobacterium animalis*
  • Female
  • Gastrointestinal Microbiome*
  • Humans
  • Hypertension* / prevention & control
  • Lacticaseibacillus rhamnosus*
  • Mice
  • Probiotics* / therapeutic use